Publications by authors named "Arisa Masuda"

Claim this Profile
D
Discovery of FXR/PPARγ dual partial agonist.
Yukiko Yamashita, Keigo Gohda, Yusuke Iguchi, Ko Fujimori, Keisuke Oda, Arisa Masuda

Bioorg Med Chem· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and identification of a new farnesoid X receptor (FXR) partial agonist by computational structure-activity relationship analysis: Ligand-induced H8 helix fluctuation in the ligand-binding domain of FXR may lead to partial agonism.
Keigo Gohda, Yusuke Iguchi, Arisa Masuda, Ko Fujimori, Yukiko Yamashita

Bioorg Med Chem Lett· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Orally Active and Nonsteroidal Farnesoid X Receptor (FXR) Antagonist with Propensity for Accumulation and Responsiveness in Ileum.
Naoki Teno, Yusuke Iguchi, Keisuke Oda, Yukiko Yamashita, Arisa Masuda

ACS Med Chem Lett· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-Substituted benzimidazole scaffold for farnesoid X receptor (FXR) agonists accompanying prominent selectivity against vitamin D receptor (VDR).
Arisa Masuda, Keigo Gohda, Yusuke Iguchi, Ko Fujimori, Yukiko Yamashita

Bioorg Med Chem· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of potent farnesoid X receptor (FXR) antagonist showing favorable PK profile and distribution toward target tissues: Comprehensive understanding of structure-activity relationship of FXR antagonists.
Naoki Teno, Yukiko Yamashita, Arisa Masuda, Yusuke Iguchi, Keisuke Oda

Bioorg Med Chem· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of once weekly treatment with bortezomib in combination with lenalidomide and dexamethasone for relapsed or refractory multiple myeloma.
Haruhito Totani, Masaki Ri, Chie Kato, Takahiro Nakashima, Nana Suzuki, Arisa Masuda

Int J Hematol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Labial salivary gland biopsy for diagnosing immunoglobulin light chain amyloidosis: a retrospective analysis.
Tomotaka Suzuki, Shigeru Kusumoto, Taro Yamashita, Arisa Masuda, Shiori Kinoshita

Ann Hematol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel type of plasmin inhibitors: providing insight into P4 moiety and alternative scaffold to pyrrolopyrimidine.
Naoki Teno, Keigo Gohda, Keiko Wanaka, Yuko Tsuda, Maiko Akagawa, Arisa Masuda

Bioorg Med Chem· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Transplant-Related Mortality Following Allogeneic Hematopoietic Stem Cell Transplantation Using Fludarabine/Busulfan-Based Reduced-Intensity Conditioning - A Retrospective Analysis in a Single Institution].
Takashi Yoshida, Shigeru Kusumoto, Arisa Masuda, Haruhito Totani, Tomoko Narita

Gan To Kagaku Ryoho· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reactivation of hepatitis B virus (HBV) infection in adult T-cell leukemia-lymphoma patients with resolved HBV infection following systemic chemotherapy.
Haruhito Totani, Shigeru Kusumoto, Takashi Ishida, Arisa Masuda, Takashi Yoshida

Int J Hematol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Case Report; An intestinal extranodal NK/T cell lymphoma mimicking Crohn's disease].
Satoru Kominato, Shigeru Kusumoto, Arisa Masuda, Takashi Ishida, Hirokazu Komatsu

Nihon Naika Gakkai Zasshi· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis